Beyond Opioids: A Multidisciplinary Approach to Cancer Pain Management

Desiree R Azizoddin^{1

2}, Hailey W Bulls^{3

4}, Hyeun Ah Kang⁵, Andrea C Enzinger²

Affiliations

¹ Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA.
² Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.
³ Challenges in Managing and Preventing Pain (CHAMPP) Clinical Research Center, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
⁴ Section of Palliative Care and Medical Ethics, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
⁵ Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, TX.

Editorial

Desiree R Azizoddin et al. JCO Oncol Pract. 2025.

. 2025 Jun 10:OP2500258.

doi: 10.1200/OP-25-00258. Online ahead of print.

Desiree R Azizoddin^{1

2}, Hailey W Bulls^{3

4}, Hyeun Ah Kang⁵, Andrea C Enzinger²

¹ Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA.
² Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.
³ Challenges in Managing and Preventing Pain (CHAMPP) Clinical Research Center, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
⁴ Section of Palliative Care and Medical Ethics, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
⁵ Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, TX.

No abstract available

References

1. Azizoddin DR, Knoerl R, Adam R, et al. Cancer pain self‐management in the context of a national opioid epidemic: Experiences of patients with advanced cancer using opioids. Cancer. 2021;127(17):3239–3245. - PMC - PubMed
1. Enzinger AC, Ghosh K, Keating NL, Cutler DM, Landrum MB, Wright AA. US trends in opioid access among patients with poor prognosis cancer near the end-of-life. Journal of clinical oncology. 2021;39(26):2948–2958. - PMC - PubMed
1. Kang HA, Wang B, Barner JC, Ataga K, Mignacca R. Unintended Consequences of the CDC’s 2016 Opioid Guideline on Individuals With Sickle Cell Disease. American Journal of Pharmaceutical Education. 2023;87(8):100162.
1. Bulls HW, Hamm M, Wasilewski J, Olejniczak D, Bell SG, Liebschutz JM. “To prescribe or not to prescribe, that is the question”: Perspectives on opioid prescribing for chronic, cancer‐related pain from clinicians who treat pain in survivorship. Cancer. 2024;130(17):3034–3042. - PubMed
1. O’Regan A, Fish LJ, Makarushka C, et al. Managing chronic pain in cancer survivorship: communication challenges and opportunities as described by cancer survivors. American Journal of Hospice and Palliative Medicine^®. 2024;41(1):78–86. - PubMed